Consolidated Statements of Income - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenue
Capitation, net	$ 272,921,240	$ 247,639,181
Risk pool settlements and incentives	44,598,373	22,641,884
Management fee income	26,983,695	24,774,941
Fee-for-service, net	11,712,965	9,163,970
Other income	1,531,137	1,714,939
Total revenue	357,747,410	305,934,915
Expenses
Cost of services	274,656,697	254,774,585
General and administrative expenses	26,437,602	21,032,971
Depreciation and amortization	19,075,353	18,114,440
Impairment of goodwill and intangibles	2,431,791	324,306
Total expenses	322,601,443	294,246,302
Income from operations	35,145,967	11,688,613
Other income (expense)
(Loss) income from equity method investments	(1,112,541)	4,748,542
Interest expense	(79,689)	(61,589)
Interest income	1,015,204	504,696
Change in fair value of derivative instrument	(44,886)	1,722,221
Gain on settlement of preexisting note receivable from ApolloMed	921,938	0
Gain from investments - fair value adjustments	13,697,018	0
Other income	168,102	233,726
Total other income, net	14,565,146	7,147,596
Income before provision for income taxes	49,711,113	18,836,209
Provision for income taxes	3,886,785	8,816,412
Net income	45,824,328	10,019,797
Net income (loss) attributable to noncontrolling interests	20,022,486	(1,433,730)
Net income attributable to Apollo Medical Holdings, Inc.	$ 25,801,842	$ 11,453,527
Earnings per share - basic	$ 1.01	$ 0.46
Earnings per share - diluted	$ 0.90	$ 0.41
Weighted average shares of common stock outstanding - basic	25,525,786	24,673,081
Weighted average shares of common stock outstanding -diluted	28,661,735	27,970,431